Literature DB >> 12525622

Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells.

Serani L H van Dommelen1, Hyacinth A Tabarias, Mark J Smyth, Mariapia A Degli-Esposti.   

Abstract

NK1.1+ T (NKT) cells are efficient regulators of early host responses which have been shown to play a role in tumor surveillance. The relevance of NKT cells in immune surveillance of viral infections, however, is not well understood. In this study, we investigated the functional relevance of NKT cells in controlling herpesvirus infections by using challenge with murine cytomegalovirus (MCMV) as the study model. This model has proven to be one of the best systems for evaluating the role of NK cells during virus infection. Using gene-targeted mice and alpha-galactosylceramide (alpha-GalCer) as an exogenous stimulator of NKT cells, we have analyzed the role of these cells in the immune surveillance of MCMV infection. Our studies in NKT-cell-deficient, T-cell receptor Jalpha281 gene-targeted mice have established that classical NKT cells do not play a critical role in the early clearance of MCMV infection. Importantly, however, activation of NKT cells by alpha-GalCer resulted in reduced viral replication in visceral organs. Depletion studies, coupled with analysis of gene-targeted mice lacking perforin and gamma interferon (IFN-gamma), have revealed that the antiviral effects of alpha-GalCer involve NK cells and have clearly demonstrated that the antiviral activity of alpha-GalCer, unlike the antitumor one, is critically dependent on both perforin and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525622      PMCID: PMC140953          DOI: 10.1128/jvi.77.3.1877-1884.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.

Authors:  N Singh; S Hong; D C Scherer; I Serizawa; N Burdin; M Kronenberg; Y Koezuka; L Van Kaer
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; H Sato; E Kondo; M Harada; H Koseki; T Nakayama; Y Tanaka; M Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

4.  Perforin is a major contributor to NK cell control of tumor metastasis.

Authors:  M J Smyth; K Y Thia; E Cretney; J M Kelly; M B Snook; C A Forbes; A A Scalzo
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

5.  Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

Authors:  N Burdin; L Brossay; M Kronenberg
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

6.  A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.

Authors:  M Tomura; W G Yu; H J Ahn; M Yamashita; Y F Yang; S Ono; T Hamaoka; T Kawano; M Taniguchi; Y Koezuka; H Fujiwara
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

7.  Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production.

Authors:  R Nakagawa; K Motoki; H Nakamura; H Ueno; R Iijima; A Yamauchi; S Tsuyuki; T Inamoto; Y Koezuka
Journal:  Oncol Res       Date:  1998       Impact factor: 5.574

8.  Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.

Authors:  N Burdin; L Brossay; Y Koezuka; S T Smiley; M J Grusby; M Gui; M Taniguchi; K Hayakawa; M Kronenberg
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

9.  The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Authors:  H Kitamura; K Iwakabe; T Yahata; S Nishimura; A Ohta; Y Ohmi; M Sato; K Takeda; K Okumura; L Van Kaer; T Kawano; M Taniguchi; T Nishimura
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.

Authors:  L Brossay; M Chioda; N Burdin; Y Koezuka; G Casorati; P Dellabona; M Kronenberg
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  52 in total

Review 1.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 2.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 3.  Immune evasion of the CD1d/NKT cell axis.

Authors:  Randy R Brutkiewicz; Laura Yunes-Medina; Jianyun Liu
Journal:  Curr Opin Immunol       Date:  2018-05-04       Impact factor: 7.486

Review 4.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

5.  Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis.

Authors:  Laurent Mesnard; Alexandre C Keller; Marie-Laure Michel; Sophie Vandermeersch; Cédric Rafat; Emmanuel Letavernier; Yves Tillet; Eric Rondeau; Maria C Leite-de-Moraes
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

6.  Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals.

Authors:  Aaron J Tyznik; Emmanuel Tupin; Niranjana A Nagarajan; Min J Her; Chris A Benedict; Mitchell Kronenberg
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 7.  NKT cell immune responses to viral infection.

Authors:  Marlowe S Tessmer; Ayesha Fatima; Christophe Paget; Francois Trottein; Laurent Brossay
Journal:  Expert Opin Ther Targets       Date:  2009-02       Impact factor: 6.902

8.  Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity.

Authors:  Jihye Han; Seung Bae Rho; Jae Yeon Lee; Joonbeom Bae; Se Ho Park; Suk Jun Lee; Sang Yeol Lee; Curie Ahn; Jae Young Kim; Taehoon Chun
Journal:  Mol Cells       Date:  2013-11-08       Impact factor: 5.034

9.  Inhibition of CD1 antigen presentation by human cytomegalovirus.

Authors:  Martin J Raftery; Manuel Hitzler; Florian Winau; Thomas Giese; Bodo Plachter; Stefan H E Kaufmann; Günther Schönrich
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

Review 10.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.